Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aspartyl/asparaginyl beta-hydroxylase | Login | Aspartyl/asparaginyl beta-hydroxylase | ||||||||||||||||
|
||||||||||||||||||
| Aspartyl/asparaginyl beta-hydroxylase | Login | Aspartyl/asparaginyl beta-hydroxylase | ||||||||||||||||
|
||||||||||||||||||
| Aspartyl/asparaginyl beta-hydroxylase | Login | Aspartyl/asparaginyl beta-hydroxylase | ||||||||||||||||
|
||||||||||||||||||
| Keratin, type I cytoskeletal 19 | Login | Keratin, type I cytoskeletal 19 | ||||||||||||||||
|
||||||||||||||||||
| Keratin, type I cytoskeletal 19 | Login | Keratin, type I cytoskeletal 19 | ||||||||||||||||
|
||||||||||||||||||
| Keratin, type I cytoskeletal 19 | Login | Keratin, type I cytoskeletal 19 | ||||||||||||||||
|
||||||||||||||||||
| Androgen receptor | Login | Androgen receptor | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Bovine Adiponectin(ADIPOQ) | Login | Recombinant Bovine Adiponectin(ADIPOQ) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Bovine Adiponectin(ADIPOQ) | Login | Recombinant Bovine Adiponectin(ADIPOQ) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mouse Tyrosine-protein kinase JAK3(Jak3) ,partial | Login | Recombinant Mouse Tyrosine-protein kinase JAK3(Jak3) ,partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mouse Tyrosine-protein kinase JAK3(Jak3) ,partial | Login | Recombinant Mouse Tyrosine-protein kinase JAK3(Jak3) ,partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mouse Hepatocellular carcinoma-associated protein TD26 homolog(Gm6484) | Login | Recombinant Mouse Hepatocellular carcinoma-associated protein TD26 homolog(Gm6484) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mouse Hepatocellular carcinoma-associated protein TD26 homolog(Gm6484) | Login | Recombinant Mouse Hepatocellular carcinoma-associated protein TD26 homolog(Gm6484) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Killer cell lectin-like receptor subfamily G member 1(KLRG1),partial | Login | Recombinant Human Killer cell lectin-like receptor subfamily G member 1(KLRG1),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Killer cell lectin-like receptor subfamily G member 1(KLRG1),partial | Login | Recombinant Human Killer cell lectin-like receptor subfamily G member 1(KLRG1),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Mixed lineage kinase domain-like protein(MLKL) | Login | Recombinant Human Mixed lineage kinase domain-like protein(MLKL) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Mixed lineage kinase domain-like protein(MLKL) | Login | Recombinant Human Mixed lineage kinase domain-like protein(MLKL) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Macrophage migration inhibitory factor(MIF) | Login | Recombinant Human Macrophage migration inhibitory factor(MIF) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Macrophage migration inhibitory factor(MIF) | Login | Recombinant Human Macrophage migration inhibitory factor(MIF) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Cathepsin B(CTSB),partial | Login | Recombinant Human Cathepsin B(CTSB),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Cathepsin B(CTSB),partial | Login | Recombinant Human Cathepsin B(CTSB),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Intercellular adhesion molecule 1(ICAM1),partial | Login | Recombinant Human Intercellular adhesion molecule 1(ICAM1),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Intercellular adhesion molecule 1(ICAM1),partial | Login | Recombinant Human Intercellular adhesion molecule 1(ICAM1),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Tumor necrosis factor receptor superfamily member 1A(TNFRSF1A),partial | Login | Recombinant Human Tumor necrosis factor receptor superfamily member 1A(TNFRSF1A),partial | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human Tumor necrosis factor receptor superfamily member 1A(TNFRSF1A),partial | Login | Recombinant Human Tumor necrosis factor receptor superfamily member 1A(TNFRSF1A),partial | ||||||||||||||||
|
||||||||||||||||||


